400 related articles for article (PubMed ID: 36268025)
21. Efficient Inhibition of Avian and Seasonal Influenza A Viruses by a Virus-Specific Dicer-Substrate Small Interfering RNA Swarm in Human Monocyte-Derived Macrophages and Dendritic Cells.
Jiang M; Österlund P; Westenius V; Guo D; Poranen MM; Bamford DH; Julkunen I
J Virol; 2019 Feb; 93(4):. PubMed ID: 30463970
[TBL] [Abstract][Full Text] [Related]
22. Interference between rhinovirus and influenza A virus: a clinical data analysis and experimental infection study.
Wu A; Mihaylova VT; Landry ML; Foxman EF
Lancet Microbe; 2020 Oct; 1(6):e254-e262. PubMed ID: 33103132
[TBL] [Abstract][Full Text] [Related]
23. Influenza A Virus Dysregulates Host Histone Deacetylase 1 That Inhibits Viral Infection in Lung Epithelial Cells.
Nagesh PT; Husain M
J Virol; 2016 May; 90(9):4614-4625. PubMed ID: 26912629
[TBL] [Abstract][Full Text] [Related]
24. Prolonged Primary Rhinovirus Infection of Human Nasal Epithelial Cells Diminishes the Viral Load of Secondary Influenza H3N2 Infection via the Antiviral State Mediated by RIG-I and Interferon-Stimulated Genes.
Ong HH; Liu J; Oo Y; Thong M; Wang Y; Chow VT
Cells; 2023 Apr; 12(8):. PubMed ID: 37190061
[TBL] [Abstract][Full Text] [Related]
25. Casein Kinase 1α Mediates the Degradation of Receptors for Type I and Type II Interferons Caused by Hemagglutinin of Influenza A Virus.
Xia C; Wolf JJ; Vijayan M; Studstill CJ; Ma W; Hahm B
J Virol; 2018 Apr; 92(7):. PubMed ID: 29343571
[TBL] [Abstract][Full Text] [Related]
26. Antiviral responses versus virus-induced cellular shutoff: a game of thrones between influenza A virus NS1 and SARS-CoV-2 Nsp1.
Khalil AM; Nogales A; Martínez-Sobrido L; Mostafa A
Front Cell Infect Microbiol; 2024; 14():1357866. PubMed ID: 38375361
[TBL] [Abstract][Full Text] [Related]
27. Fibroblast growth factor-9 expression in airway epithelial cells amplifies the type I interferon response and alters influenza A virus pathogenesis.
Hiller BE; Yin Y; Perng YC; de Araujo Castro Í; Fox LE; Locke MC; Monte KJ; López CB; Ornitz DM; Lenschow DJ
PLoS Pathog; 2022 Jun; 18(6):e1010228. PubMed ID: 35675358
[TBL] [Abstract][Full Text] [Related]
28. IFITM Proteins That Restrict the Early Stages of Respiratory Virus Infection Do Not Influence Late-Stage Replication.
Meischel T; Fritzlar S; Villalon-Letelier F; Tessema MB; Brooks AG; Reading PC; Londrigan SL
J Virol; 2021 Sep; 95(20):e0083721. PubMed ID: 34319159
[TBL] [Abstract][Full Text] [Related]
29. A host susceptibility gene, DR1, facilitates influenza A virus replication by suppressing host innate immunity and enhancing viral RNA replication.
Hsu SF; Su WC; Jeng KS; Lai MM
J Virol; 2015 Apr; 89(7):3671-82. PubMed ID: 25589657
[TBL] [Abstract][Full Text] [Related]
30. IRF5 Promotes Influenza Virus-Induced Inflammatory Responses in Human Induced Pluripotent Stem Cell-Derived Myeloid Cells and Murine Models.
Forbester JL; Clement M; Wellington D; Yeung A; Dimonte S; Marsden M; Chapman L; Coomber EL; Tolley C; Lees E; Hale C; Clare S; Udalova I; Dong T; Dougan G; Humphreys IR
J Virol; 2020 Apr; 94(9):. PubMed ID: 32075938
[TBL] [Abstract][Full Text] [Related]
31. Type III interferons are critical host factors that determine susceptibility to Influenza A viral infection in allergic nasal mucosa.
Jeon YJ; Lim JH; An S; Jo A; Han DH; Won TB; Kim DY; Rhee CS; Kim HJ
Clin Exp Allergy; 2018 Mar; 48(3):253-265. PubMed ID: 29288502
[TBL] [Abstract][Full Text] [Related]
32. Influenza a virus NS1 resembles a TRAF3-interacting motif to target the RNA sensing-TRAF3-type I IFN axis and impair antiviral innate immunity.
Lin CY; Shih MC; Chang HC; Lin KJ; Chen LF; Huang SW; Yang ML; Ma SK; Shiau AL; Wang JR; Chen KR; Ling P
J Biomed Sci; 2021 Oct; 28(1):66. PubMed ID: 34610835
[TBL] [Abstract][Full Text] [Related]
33. PGRMC1 Exerts Its Function of Anti-Influenza Virus in the Central Nervous System.
Huang K; Zhang Y; Gong W; Yang Y; Jiang L; Zhao L; Yang Y; Wei Y; Li C; He X; Sun X; Zou Z; Jin M
Microbiol Spectr; 2021 Oct; 9(2):e0073421. PubMed ID: 34585989
[TBL] [Abstract][Full Text] [Related]
34. Late Endosomal/Lysosomal Cholesterol Accumulation Is a Host Cell-Protective Mechanism Inhibiting Endosomal Escape of Influenza A Virus.
Kühnl A; Musiol A; Heitzig N; Johnson DE; Ehrhardt C; Grewal T; Gerke V; Ludwig S; Rescher U
mBio; 2018 Jul; 9(4):. PubMed ID: 30042202
[TBL] [Abstract][Full Text] [Related]
35. Influenza A virus activates cellular Tropomyosin receptor kinase A (TrkA) signaling to promote viral replication and lung inflammation.
Verma V; Dileepan M; Huang Q; Phan T; Hu WS; Ly H; Liang Y
PLoS Pathog; 2022 Sep; 18(9):e1010874. PubMed ID: 36121891
[TBL] [Abstract][Full Text] [Related]
36. Host-Pathogen Responses to Pandemic Influenza H1N1pdm09 in a Human Respiratory Airway Model.
Pharo EA; Williams SM; Boyd V; Sundaramoorthy V; Durr PA; Baker ML
Viruses; 2020 Jun; 12(6):. PubMed ID: 32599823
[TBL] [Abstract][Full Text] [Related]
37. Hemagglutinin of Influenza A Virus Antagonizes Type I Interferon (IFN) Responses by Inducing Degradation of Type I IFN Receptor 1.
Xia C; Vijayan M; Pritzl CJ; Fuchs SY; McDermott AB; Hahm B
J Virol; 2015 Dec; 90(5):2403-17. PubMed ID: 26676772
[TBL] [Abstract][Full Text] [Related]
38. Inducible Guanylate-Binding Protein 7 Facilitates Influenza A Virus Replication by Suppressing Innate Immunity via NF-κB and JAK-STAT Signaling Pathways.
Feng M; Zhang Q; Wu W; Chen L; Gu S; Ye Y; Zhong Y; Huang Q; Liu S
J Virol; 2021 Feb; 95(6):. PubMed ID: 33408175
[TBL] [Abstract][Full Text] [Related]
39. The Role of Type I IFNs in Influenza: Antiviral Superheroes or Immunopathogenic Villains?
Wu W; Metcalf JP
J Innate Immun; 2020; 12(6):437-447. PubMed ID: 32564033
[TBL] [Abstract][Full Text] [Related]
40. Interplay of PA-X and NS1 Proteins in Replication and Pathogenesis of a Temperature-Sensitive 2009 Pandemic H1N1 Influenza A Virus.
Nogales A; Rodriguez L; DeDiego ML; Topham DJ; Martínez-Sobrido L
J Virol; 2017 Sep; 91(17):. PubMed ID: 28637750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
